Renal sympathetic denervation for the treatment of hypertensive heart
disease with systolic heart failure

doi:10.11958/20150136

Tianjin Med J ›› 2016, Vol. 44 ›› Issue (2): 234-236.doi: 10.11958/20150136

Previous Articles Next Articles

Renal sympathetic denervation for the treatment of hypertensive heart disease with systolic heart failure

XIA Dasheng, LU Chengzhi, WANG Li

Department of Cardiology of Tianjin First Center Hospital, Tianjin 300192,China

Received:2015-08-31 Revised:2015-10-29 Published:2016-02-15 Online:2016-02-15

XIA Dasheng, LU Chengzhi, WANG Li. Renal sympathetic denervation for the treatment of hypertensive heart disease with systolic heart failure[J]. Tianjin Med J, 2016, 44(2): 234-236.

Abstract

Abstract: Objective To evaluate the effectiveness of renal sympathetic denervation (RDN) for hypertensive heart dis⁃ ease combined with systolic heart failure. Methods Two patients (mean age 35 years) with hypertensive heart disease combined with systolic heart failure on maximal tolerated heart failure therapy underwent bilateral renal denervation. Echocardiography, the six minute walk distance, renal function, glycosylated hemoglobin and NT-proBNP were assessed at baseline and 1 year after renal denervation. Results Renal artery angiography showed that no stenosis and dissection. After 1 year follow up, the left ventricular ejection fraction (LVEF), six minute walk distance and NT- proBNP were significantly improved, and the size of left ventricular decreased. Conclusion RDN is effective and feasible for the treatment in patients with hypertensive heart disease and systolic heart failure.

Key words: renal sympathetic denervation, systolic heart failure, hypertension

[1]	WU Caixin, YAN Yan, DENG Yuanlin, DU Yamin, YANG Zhenwen, PAN Qing, YANG Fan. The value of cardiac magnetic resonance in evaluating severe pulmonary hypertension associated with connective tissue disease [J]. Tianjin Medical Journal, 2024, 52(7): 691-694.
[2]	WANG Hui, PAN Qing, WANG Zhouming, ZHANG Na, YANG Zhenwen, WEI Wei. Analysis of clinical features of mixed connective tissue disease associated with pulmonary arterial hypertension [J]. Tianjin Medical Journal, 2024, 52(7): 701-703.
[3]	LI Yong, SU Yakun, ZHANG Hongbo, LI Yuan, LI Zhanhu, YAN Xiaoju. Clinical significance of serum asprosin level in patients with early renal damage of essential hypertension [J]. Tianjin Medical Journal, 2024, 52(6): 609-613.
[4]	ZHENG Kangpeng, TANG Xinguo, XU Qi, FAN Yuting, LIANG Bo, FU Xiaowei, FANG Lu. Nomogram construction and validation for predicting the possibility successful implementation of radical surgery in gallbladder cancer patients [J]. Tianjin Medical Journal, 2024, 52(5): 536-540.
[5]	ZHANG Liran, ZHAO Yanhua. The predictive value of MP hypertension monitoring system combined with PLGF and PI for preeclampsia [J]. Tianjin Medical Journal, 2024, 52(3): 306-310.
[6]	CAO Junyang, MA Chunxing, LIU Zhina. Predictive value of vitamin and folic acid levels in gestational diabetes mellitus complicated by preeclampsia [J]. Tianjin Medical Journal, 2024, 52(12): 1278-1282.
[7]	QIN Chundi, MA Wen, LI Yuan, ZHU Yaquan, LI Yu, ZOU Lin, ZHANG Xin. Butyrate reduces blood pressure in hypertensive rats by activating the G protein-coupled receptor 41/43 pathway [J]. Tianjin Medical Journal, 2023, 51(9): 972-976.
[8]	ZHANG Zhaoxia, NAN Xingmei, LI Zhanqiang, LU Dianxiang. Research progress on the role of potassium channels and drug intervention in hypoxic pulmonary hypertension [J]. Tianjin Medical Journal, 2023, 51(8): 892-896.
[9]	ZHANG Wenjing, WEN Dehui, ZHENG Yingjuan, LI Chaoxi, NIU Yajun, MIAO Qing. The study of QAS combined with QIMT technology on carotid atherosclerosis in patients with normal high blood pressure [J]. Tianjin Medical Journal, 2023, 51(6): 662-667.
[10]	ZHENG Yue, MA Yunting, ZHAO Xiaoying, ZHAO Xinxiang. Correlation between homocysteine and left ventricular myocardial fibrosis in hypertensive patients [J]. Tianjin Medical Journal, 2023, 51(4): 395-399.
[11]	LU Rongzhen, HUANG Jiangnan, PAN Xingshou, LU Ting, LI Jindu, LI Tianzi, TAN Shuhan. Application effect research of different antihypertensive modes in elderly hypertensive patients with coronary heart disease and PCI [J]. Tianjin Medical Journal, 2023, 51(3): 277-281.
[12]	YANG Guohong, YU Fangfang, CAI Wei, NIU Xiulong, ZHANG Xin, ZHAO Jihong, LI Yuming, CHEN Shaobo. Effects of peripheral blood VEGFR-3⁺ monocytes on left ventricular remodeling in mice with hypertension [J]. Tianjin Medical Journal, 2023, 51(2): 144-148.
[13]	XU Xuemei, LI Chunyan, DENG Zhihong, XU Xiaoming, SHI Jing. Analysis of macular choroidal thickness in patients with grade 3 essential hypertension [J]. Tianjin Medical Journal, 2023, 51(2): 176-179.
[14]	LI Jing, FAN Zhuoran, ZHANG Junnong, SHENG Hongna, HUA Shaofang. Comparative study on clinical characteristics and TyG index in patients with premature preeclampsia and chronic hypertension complicated with preeclampsia [J]. Tianjin Medical Journal, 2023, 51(2): 190-193.
[15]	YANG Xueyuan, FENG Chao, FENG Jinping. The influence of blood pressure fluctuation on poor prognosis in patients with severe aortic stenosis [J]. Tianjin Medical Journal, 2023, 51(10): 1110-1116.

Renal sympathetic denervation for the treatment of hypertensive heart disease with systolic heart failure

Cite this article

PDF (PC)

Knowledge

Abstract

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments